{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"progressive-myoclonic-epilepsy-type-3","columns":[{"countQualifier":"Onset group unspecified","gene":"KCTD7","key":"population-70813dceff900d6c0f82","label":"KCTD7 / CLN14-linked entry","mondoId":"MONDO:0012721","onsetQualifier":null,"originColumnKey":"MONDO:0012721","originalViews":[{"key":"MONDO:0012721","label":"KCTD7 / CLN14-linked entry","scopeLabel":"Broader source entry","sourceScope":"Broader progressive myoclonic epilepsy entry, not CLN14-only"}],"recordKeys":["09290b5c077ddb9cd720b742b800b7d1346c1f5f6c2a8b06dcd34d0239c36407","37ad0e6ca5255693e31a8efdeaa593c2553f935cda28a58a675f49ac41b20925","3ef3d2af4eb13ee1237599c4e74f3a29ae169e4d8670791b5731fc9984e37d6e","499823fc6421ee8a476ba6f5f9607dc5a7841da353e0bfd778fd4f793ee04ec8","4b72b6c0ac17ad5d882c633ee5c401055f7e904e35285da6b9f25efe9537a021","52df3ccfdb0319fe85e35ebcd00233c8de7a51990253d555a229518e9c0c139a","5cbc65461b1f3e719678a1e83483e35f41f5abaaabf72fffe07137b30d4c2943","60ec141db72c79bb26793b818869d1888adfef020a8ef5a49ff54646038d7e67","9e6931d220b6902ed421c2d7a27c9a3d9c0b27555520f573d01b5475553b661e","a4b49f0f35c2504adc71f33e2505266e0201fd3eca847d6ccd726803204afb29","bc43d035a9e8205a1701a11fdebe9faff19a028110a0b8451a934a3b5354fad8","bcf6e8c82a899c6ce96e3a7991e5a22492e4675d74533d3d1d3e0b0131652fb4","caa9abcba0c7b6eb5e3ae8b048b95251b3b0e275fcbd634589534cf638e0d5ef","d42e4f0cc10b08f0934569229b5e545ebe7aa37bddd06359b526fbb172d81915","db8f3c4b7dc6caa11569d9fce2888763667547f331b3e316d2fe7156c6a279b5","fdf4ef5a15b517687a733e6009f47a93e5d6823ffb14e432a28315fc8d8c0c92"],"recordQualifiers":{"09290b5c077ddb9cd720b742b800b7d1346c1f5f6c2a8b06dcd34d0239c36407":"Onset group unspecified","499823fc6421ee8a476ba6f5f9607dc5a7841da353e0bfd778fd4f793ee04ec8":"Onset group unspecified","4b72b6c0ac17ad5d882c633ee5c401055f7e904e35285da6b9f25efe9537a021":"Onset group unspecified","52df3ccfdb0319fe85e35ebcd00233c8de7a51990253d555a229518e9c0c139a":"Onset group unspecified","5cbc65461b1f3e719678a1e83483e35f41f5abaaabf72fffe07137b30d4c2943":"Onset group unspecified","9e6931d220b6902ed421c2d7a27c9a3d9c0b27555520f573d01b5475553b661e":"Onset group unspecified","bc43d035a9e8205a1701a11fdebe9faff19a028110a0b8451a934a3b5354fad8":"Onset group unspecified","bcf6e8c82a899c6ce96e3a7991e5a22492e4675d74533d3d1d3e0b0131652fb4":"Onset group unspecified","caa9abcba0c7b6eb5e3ae8b048b95251b3b0e275fcbd634589534cf638e0d5ef":"Onset group unspecified","db8f3c4b7dc6caa11569d9fce2888763667547f331b3e316d2fe7156c6a279b5":"Onset group unspecified","fdf4ef5a15b517687a733e6009f47a93e5d6823ffb14e432a28315fc8d8c0c92":"Onset group unspecified"},"scopeLabel":"Broader source entry","sourceIds":["OMIM:611726"],"sourceScope":"Broader progressive myoclonic epilepsy entry, not CLN14-only"},{"gene":"","key":"population-1057aacd7ea44c718bce","label":"Progressive myoclonic epilepsy type 3","mondoId":"MONDO:0012721","onsetQualifier":null,"originColumnKey":"MONDO:0012721/ORPHA:263516","originalViews":[{"key":"MONDO:0012721/ORPHA:263516","label":"Progressive myoclonic epilepsy type 3","scopeLabel":"ORPHA:263516","sourceScope":"This column retains this exact native source population. It is not a pooled family estimate."}],"recordKeys":["0aebeeb93b1e0aca64a2ac4ce4621f5cc0191618d2efbc18b7fbb9844eb90990","0d7e2b9df13202d5163a4b9ad613c3c9c92568fb0d88743bbb575e6c37a223e6","0df22b70ed4a72ea59cfa780f5ba3381f45f3eca3dcf30ba2272539ffc73f4af","18647e91c1ca898b4dabaed9924e1aab6ed804787f62d1b3f01082d696aea2a1","18a7c3e7f00167786a9794d4a3e52c324fea7ff9a77ea9f2ba2e9608e0cb8311","28ccd68fb89ba78dfbe5a39a80dd9a50f59f26e7ef686a91fead24641f7930c9","2d0c0311c9e229ae50d67b034ada0ddea1c041f0c1540f2b1588ede2cd73fbcb","51c4e2ca251c05095c4c793642edf4c5182fe30ce6fb04d91a20eace58e85124","5758a9d3a45fff13b4dbfa72100861dc0126caf17cc6cace44989fc5bec83cac","5f6151bdb972f5e98e17be8470d85915d5a0a15f0537c74ed48fa5b8cc394c4c","69c7115ed14f5247bc02424e6b79ef1ece549ffd07080d8f23b1616b5087e148","6ec450e9cccf86fe61aafb9dd64b4a95af0f7f4585f4e02b53ca5ef4b128154b","70412b949bdb3983e64e59962b2da86944b87bc0cfa30a866fec8b9995db7209","78e0786cd5907cbe6c8484ff4b800164df665fc2f602934eeb80ead38104c961","86f297d5f1da62e59d086971eebad03a9a0aafe56acc82b9b628df7f33bcaf41","87b19542b3de4e566c019597dead4463ff53aa4d43d1192e72afb2fda39805b1","8c577ddce41d05daf397cf99f6ab82e6a19ff6879f41b74cee1756356e49b4d4","916fb662dca75cbae49236dcd397c9bb56952fd399b65356445c39d47cae58c3","9d3f0fb91e45c13007db4417436ddcd7dfbedf602768c48c247f7b445ffd49b4","a058dd5cea73a15cc0391ea5899c4f36a185f3708777ac6c10f3bcf299f212fd","b8c4ce4854d6b6137c04ecf20fbc2e432114f3967c2f0357669690bef806f494","f93df624bfe2c25ae537ea44157fa3717d293683a3526a730a678da155318e0f"],"recordQualifiers":{},"scopeLabel":"ORPHA:263516","sourceIds":["ORPHA:263516"],"sourceScope":"This column retains this exact native source population. It is not a pooled family estimate."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-70813dceff900d6c0f82","population-1057aacd7ea44c718bce"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000504","HP:0001344","HP:0007370","HP:0002069","HP:0007334","HP:0001272","HP:0002059"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":12,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":38,"sourceGroups":{"omim":3,"orphanet":22,"published":13}},"features":[{"hpoId":"HP:0000504","label":"Abnormality of vision","primary":true},{"hpoId":"HP:0001344","label":"Absent speech","primary":true},{"hpoId":"HP:0007370","label":"Aplasia/Hypoplasia of the corpus callosum","primary":true},{"hpoId":"HP:0002069","label":"Bilateral tonic-clonic seizure","primary":true},{"hpoId":"HP:0007334","label":"Bilateral tonic-clonic seizure with focal onset","primary":true},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0012462","label":"Chin myoclonus","primary":false},{"hpoId":"HP:0000726","label":"Dementia","primary":false},{"hpoId":"HP:0002376","label":"Developmental regression","primary":false},{"hpoId":"HP:0001260","label":"Dysarthria","primary":false},{"hpoId":"HP:0011185","label":"EEG with focal epileptiform discharges","primary":false},{"hpoId":"HP:0002373","label":"Febrile seizure (within the age range of 3 months to 6 years)","primary":false},{"hpoId":"HP:0003208","label":"Fingerprint intracellular accumulation of autofluorescent lipopigment storage material","primary":false},{"hpoId":"HP:0011188","label":"Focal EEG discharges with secondary generalization","primary":false},{"hpoId":"HP:0011166","label":"Focal myoclonic seizure","primary":false},{"hpoId":"HP:0002123","label":"Generalized myoclonic seizure","primary":false},{"hpoId":"HP:0002079","label":"Hypoplasia of the corpus callosum","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0045084","label":"Limb myoclonus","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0032794","label":"Myoclonic seizure","primary":false},{"hpoId":"HP:0032667","label":"Myoclonic status epilepticus","primary":false},{"hpoId":"HP:0001336","label":"Myoclonus","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0001327","label":"Photosensitive myoclonic seizure","primary":false},{"hpoId":"HP:0002073","label":"Progressive cerebellar ataxia","primary":false},{"hpoId":"HP:0007272","label":"Progressive psychomotor deterioration","primary":false},{"hpoId":"HP:0007221","label":"Progressive truncal ataxia","primary":false},{"hpoId":"HP:0002078","label":"Truncal ataxia","primary":false},{"hpoId":"HP:0000572","label":"Visual loss","primary":false}],"ledeHtml":"Any progressive myoclonic epilepsy in which the cause of the disease is a mutation in the KCTD7 gene.","mondoId":"MONDO:0012721","node":{"canonicalSlug":"progressive-myoclonic-epilepsy-type-3","comparisons":[{"documentSha256":"feab7132c1e6efa19316faa9c5b975a6a6317da700f12b5b4c059a18eda6d069","key":"legacy-cln","kind":"legacy","label":"CLN / Batten disease","memberIds":["MONDO:0008083","MONDO:0008767","MONDO:0008768","MONDO:0008769","MONDO:0009744","MONDO:0009745","MONDO:0010830","MONDO:0011144","MONDO:0012391","MONDO:0012414","MONDO:0012588","MONDO:0012721","MONDO:0013866","MONDO:0014147","MONDO:0016295"],"mondoId":"MONDO:0016295","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cln.feab7132c1e6efa19316faa9c5b975a6a6317da700f12b5b4c059a18eda6d069.json"},{"documentSha256":"df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3","key":"expanded-cln","kind":"expanded","label":"CLN / Batten disease","memberIds":["MONDO:0008083","MONDO:0008767","MONDO:0008768","MONDO:0008769","MONDO:0009744","MONDO:0009745","MONDO:0010830","MONDO:0011144","MONDO:0012188","MONDO:0012391","MONDO:0012414","MONDO:0012588","MONDO:0012721","MONDO:0013866","MONDO:0014147","MONDO:0016295","MONDO:0017809","MONDO:0019260","MONDO:0019261","MONDO:0019262","MONDO:0030947","MONDO:0850001"],"mondoId":"MONDO:0016295","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-df7e5010cb40de30aba1.df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Progressive myoclonic epilepsy type 3","originalSourceId":"ORPHA:263516","paragraphs":["Any progressive myoclonic epilepsy in which the cause of the disease is a mutation in the KCTD7 gene."],"rawAttribution":"MONDO:0012721","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:41Z","upstream":"MONDO:0012721","url":"https://rarediseases.info.nih.gov/diseases/2167"},"ownColumnKeys":["population-70813dceff900d6c0f82","population-1057aacd7ea44c718bce"],"publication":"published","relationships":[{"kind":"parent","label":"congenital nervous system disorder","mondoId":"MONDO:0002320","slug":null},{"kind":"parent","label":"congenital disorder of glycosylation","mondoId":"MONDO:0015286","slug":"congenital-disorder-of-glycosylation"},{"kind":"parent","label":"neuronal ceroid lipofuscinosis","mondoId":"MONDO:0016295","slug":"cln"},{"kind":"parent","label":"progressive myoclonus epilepsy","mondoId":"MONDO:0020074","slug":"progressive-myoclonus-epilepsy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"count","key":"09290b5c077ddb9cd720b742b800b7d1346c1f5f6c2a8b06dcd34d0239c36407","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002079","is_excluded":false,"label":"Hypoplasia of the corpus callosum","onset_id":null,"reference":"PMID:22748208","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"0aebeeb93b1e0aca64a2ac4ce4621f5cc0191618d2efbc18b7fbb9844eb90990","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012462","is_excluded":false,"label":"Chin myoclonus","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0d7e2b9df13202d5163a4b9ad613c3c9c92568fb0d88743bbb575e6c37a223e6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0df22b70ed4a72ea59cfa780f5ba3381f45f3eca3dcf30ba2272539ffc73f4af","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0045084","is_excluded":false,"label":"Limb myoclonus","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"18647e91c1ca898b4dabaed9924e1aab6ed804787f62d1b3f01082d696aea2a1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002069","is_excluded":false,"label":"Bilateral tonic-clonic seizure","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"18a7c3e7f00167786a9794d4a3e52c324fea7ff9a77ea9f2ba2e9608e0cb8311","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011185","is_excluded":false,"label":"EEG with focal epileptiform discharges","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"28ccd68fb89ba78dfbe5a39a80dd9a50f59f26e7ef686a91fead24641f7930c9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007221","is_excluded":false,"label":"Progressive truncal ataxia","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2d0c0311c9e229ae50d67b034ada0ddea1c041f0c1540f2b1588ede2cd73fbcb","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000504","is_excluded":false,"label":"Abnormality of vision","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"37ad0e6ca5255693e31a8efdeaa593c2553f935cda28a58a675f49ac41b20925","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":"HP:0011463","reference":"PMID:22748208","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"3ef3d2af4eb13ee1237599c4e74f3a29ae169e4d8670791b5731fc9984e37d6e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0032794","is_excluded":false,"label":"Myoclonic seizure","onset_id":null,"reference":"PMID:17455289","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"499823fc6421ee8a476ba6f5f9607dc5a7841da353e0bfd778fd4f793ee04ec8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"PMID:17455289","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4b72b6c0ac17ad5d882c633ee5c401055f7e904e35285da6b9f25efe9537a021","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0007334","is_excluded":false,"label":"Bilateral tonic-clonic seizure with focal onset","onset_id":null,"reference":"PMID:17455289","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"51c4e2ca251c05095c4c793642edf4c5182fe30ce6fb04d91a20eace58e85124","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002073","is_excluded":false,"label":"Progressive cerebellar ataxia","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"52df3ccfdb0319fe85e35ebcd00233c8de7a51990253d555a229518e9c0c139a","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"PMID:22748208","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"5758a9d3a45fff13b4dbfa72100861dc0126caf17cc6cace44989fc5bec83cac","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011166","is_excluded":false,"label":"Focal myoclonic seizure","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"5cbc65461b1f3e719678a1e83483e35f41f5abaaabf72fffe07137b30d4c2943","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"PMID:17455289","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"5f6151bdb972f5e98e17be8470d85915d5a0a15f0537c74ed48fa5b8cc394c4c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"60ec141db72c79bb26793b818869d1888adfef020a8ef5a49ff54646038d7e67","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000572","is_excluded":false,"label":"Visual loss","onset_id":null,"reference":"OMIM:611726","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"69c7115ed14f5247bc02424e6b79ef1ece549ffd07080d8f23b1616b5087e148","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6ec450e9cccf86fe61aafb9dd64b4a95af0f7f4585f4e02b53ca5ef4b128154b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007272","is_excluded":false,"label":"Progressive psychomotor deterioration","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"70412b949bdb3983e64e59962b2da86944b87bc0cfa30a866fec8b9995db7209","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007370","is_excluded":false,"label":"Aplasia/Hypoplasia of the corpus callosum","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"78e0786cd5907cbe6c8484ff4b800164df665fc2f602934eeb80ead38104c961","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011188","is_excluded":false,"label":"Focal EEG discharges with secondary generalization","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"86f297d5f1da62e59d086971eebad03a9a0aafe56acc82b9b628df7f33bcaf41","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002373","is_excluded":false,"label":"Febrile seizure (within the age range of 3 months to 6 years)","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"87b19542b3de4e566c019597dead4463ff53aa4d43d1192e72afb2fda39805b1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8c577ddce41d05daf397cf99f6ab82e6a19ff6879f41b74cee1756356e49b4d4","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"916fb662dca75cbae49236dcd397c9bb56952fd399b65356445c39d47cae58c3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9d3f0fb91e45c13007db4417436ddcd7dfbedf602768c48c247f7b445ffd49b4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"9e6931d220b6902ed421c2d7a27c9a3d9c0b27555520f573d01b5475553b661e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0032667","is_excluded":false,"label":"Myoclonic status epilepticus","onset_id":null,"reference":"PMID:17455289","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a058dd5cea73a15cc0391ea5899c4f36a185f3708777ac6c10f3bcf299f212fd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001327","is_excluded":false,"label":"Photosensitive myoclonic seizure","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a4b49f0f35c2504adc71f33e2505266e0201fd3eca847d6ccd726803204afb29","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003208","is_excluded":false,"label":"Fingerprint intracellular accumulation of autofluorescent lipopigment storage material","onset_id":null,"reference":"OMIM:611726","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b8c4ce4854d6b6137c04ecf20fbc2e432114f3967c2f0357669690bef806f494","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"bc43d035a9e8205a1701a11fdebe9faff19a028110a0b8451a934a3b5354fad8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001344","is_excluded":false,"label":"Absent speech","onset_id":null,"reference":"PMID:22748208","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bcf6e8c82a899c6ce96e3a7991e5a22492e4675d74533d3d1d3e0b0131652fb4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"PMID:22748208","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"caa9abcba0c7b6eb5e3ae8b048b95251b3b0e275fcbd634589534cf638e0d5ef","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0002078","is_excluded":false,"label":"Truncal ataxia","onset_id":null,"reference":"PMID:17455289","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d42e4f0cc10b08f0934569229b5e545ebe7aa37bddd06359b526fbb172d81915","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002123","is_excluded":false,"label":"Generalized myoclonic seizure","onset_id":null,"reference":"OMIM:611726","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"db8f3c4b7dc6caa11569d9fce2888763667547f331b3e316d2fe7156c6a279b5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"PMID:22748208","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f93df624bfe2c25ae537ea44157fa3717d293683a3526a730a678da155318e0f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:263516","disease_name":"Progressive myoclonic epilepsy type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"ORPHA:263516","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"fdf4ef5a15b517687a733e6009f47a93e5d6823ffb14e432a28315fc8d8c0c92","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611726","disease_name":"Epilepsy, progressive myoclonic 3, with or without intracellular inclusions","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"PMID:22748208","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2167\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012721\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0012721</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Any progressive myoclonic epilepsy in which the cause of the disease is a mutation in the KCTD7 gene.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2167\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"progressive-myoclonic-epilepsy-type-3","sourceDocuments":[{"name":"GARD: Progressive myoclonic epilepsy type 3","reviewed":null,"source_release":"2026-10-25T03:38:41Z","url":"https://rarediseases.info.nih.gov/diseases/2167"},{"name":"MONDO: progressive myoclonic epilepsy type 3","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012721"}],"sourceNote":"","synonyms":["CLN14 disease","epilepsy progressive myoclonic type 3","epilepsy, progressive myoclonic 3, with or without intracellular inclusions","epilepsy, progressive myoclonic, 3, with or without intracellular inclusions","EPM 3","EPM3","KCTD7 progressive myoclonic epilepsy","neuronal ceroid lipofuscinosis type 14","PME type 3","progressive myoclonic epilepsy 3","progressive myoclonic epilepsy caused by mutation in KCTD7","progressive myoclonic epilepsy due to KCTD7 deficiency","progressive myoclonic epilepsy type 3","progressive myoclonus epilepsy type 3"],"takeawayHtml":"","title":"progressive myoclonic epilepsy type 3"},"schemaVersion":1}
